Fecal microbiota transplantation compared with prednisolone in severe alcoholic hepatitis patients: a randomized trial

[1] Shasthry SM(2019)Efficacy of granulocyte colony-stimulating factor in the management of steroid-nonresponsive severe alcoholic hepatitis: a double-blind randomized controlled trial Hepatology 70 802-811

[2] Sharma MK(2011)Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data Gut 60 255-260

[3] Shasthry V(2015)Prednisolone or pentoxifylline for alcoholic hepatitis N Engl J Med 372 1619-1647

[4] Pande A(2016)Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease Gut 65 830-839

[5] Sarin SK(2020)Probiotic Hepatology 71 2050-2066

[6] Mathurin P(2018) GG prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice Am J Gastroenterol 113 175-194

[7] O’Grady J(2013)ACG clinical guideline: alcoholic liver disease Nat Immunol 14 685-690

[8] Carithers RL(2019)Control of pathogens and pathobionts by the gut microbiota J Hepatol 70 260-272

[9] Phillips M(2011)Microbiome as a therapeutic target in alcohol-related liver disease Mol Cell Endocrinol 335 2-13

[10] Louvet A(2017)The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights Gastroenterology 152 1068-1077.e4

[1] Shasthry SM(2019)Efficacy of granulocyte colony-stimulating factor in the management of steroid-nonresponsive severe alcoholic hepatitis: a double-blind randomized controlled trial Hepatology 70 802-811

[2] Sharma MK(2011)Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data Gut 60 255-260

[3] Shasthry V(2015)Prednisolone or pentoxifylline for alcoholic hepatitis N Engl J Med 372 1619-1647

[4] Pande A(2016)Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease Gut 65 830-839

[5] Sarin SK(2020)Probiotic Hepatology 71 2050-2066

[6] Mathurin P(2018) GG prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice Am J Gastroenterol 113 175-194

[7] O’Grady J(2013)ACG clinical guideline: alcoholic liver disease Nat Immunol 14 685-690

[8] Carithers RL(2019)Control of pathogens and pathobionts by the gut microbiota J Hepatol 70 260-272

[9] Phillips M(2011)Microbiome as a therapeutic target in alcohol-related liver disease Mol Cell Endocrinol 335 2-13

[10] Louvet A(2017)The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights Gastroenterology 152 1068-1077.e4